Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $6.63 USD
Change Today +0.39 / 6.25%
Volume 671.0K
TXMD On Other Exchanges
Symbol
Exchange
Stuttgart
NYSE Amex
As of 2:27 PM 05/27/15 All times are local (Market data is delayed by at least 15 minutes).

therapeuticsmd inc (TXMD) Snapshot

Open
$6.36
Previous Close
$6.24
Day High
$6.75
Day Low
$6.28
52 Week High
04/22/15 - $7.49
52 Week Low
12/15/14 - $3.44
Market Cap
1.1B
Average Volume 10 Days
910.5K
EPS TTM
$-0.43
Shares Outstanding
172.7M
EX-Date
06/6/08
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for THERAPEUTICSMD INC (TXMD)

Related News

No related news articles were found.

therapeuticsmd inc (TXMD) Related Businessweek News

No Related Businessweek News Found

therapeuticsmd inc (TXMD) Details

TherapeuticsMD, Inc. operates as a women’s health care product company. The company manufactures and distributes prescription and over-the-counter product lines, including prenatal vitamins, iron supplements, vitamin D supplements, and natural menopause relief products under the vitaMedMD brand, as well as duplicate formulations of its prescription prenatal vitamins products under the BocaGreenMD Prena1 name. The company also focuses on conducting the clinical trials for hormone therapy pharmaceutical products that are designed to alleviate the symptoms of and reduce the health risks resulting from menopause-related hormone deficiencies, including hot flashes, osteoporosis, and vaginal discomfort. In addition, it manufactures and distributes branded and generic prescription prenatal, as well as OTC vitamins. TherapeuticsMD markets its products primarily through a direct national sales force to health care providers, as well as directly through its Website. The company was founded in 2008 and is headquartered in Boca Raton, Florida.

100 Employees
Last Reported Date: 03/12/15
Founded in 2008

therapeuticsmd inc (TXMD) Top Compensated Officers

Co-Founder, Chief Executive Officer and Direc...
Total Annual Compensation: $550.0K
President, Secretary and Director
Total Annual Compensation: $350.0K
Chief Financial Officer, Vice President of Fi...
Total Annual Compensation: $345.0K
Chief Strategy Officer and Executive Vice Pre...
Total Annual Compensation: $213.2K
Vice President of Finance
Total Annual Compensation: $150.0K
Compensation as of Fiscal Year 2014.

therapeuticsmd inc (TXMD) Key Developments

TherapeuticsMD, Inc. Presents at Bank of America Merrill Lynch 2015 Health Care Conference, May-13-2015 11:20 AM

TherapeuticsMD, Inc. Presents at Bank of America Merrill Lynch 2015 Health Care Conference, May-13-2015 11:20 AM. Venue: Encore at the Wynn, 3131 S Las Vegas Blvd, Las Vegas, Nevada, United States. Speakers: Robert G. Finizio, Co-Founder, Chief Executive Officer and Director.

TherapeuticsMD, Inc. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2015

TherapeuticsMD, Inc. announced unaudited consolidated earnings results for the first quarter ended March 31, 2015. For the quarter, net revenue totaled approximately $4.5 million compared with $2.8 million for the prior year’s quarter, an increase of approximately 58%. Revenue growth was primarily driven by increased sales of the company’s prenatal vitamin products and an increase in the average net sales price of the company’s products. Operating loss was $20,922,611 against $8,950,817 last year. Loss before taxes was $20,894,256 against $9,183,118 last year. Net loss was $20,894,256 or $0.13 per basic and diluted share compared with $9,183,118 or $0.06 per basic and diluted share in the prior year. Net cash flows used in operating activities was $19,149,736 against $8,705,937 a year ago.

TherapeuticsMD, Inc. Proposes an Amendment to Amended and Restated Articles of Incorporation

TherapeuticsMD, Inc. announced that at its AGM to be held on June 11, 2015, proposed an amendment to amended and restated articles of incorporation to increase the number of authorized shares of common stock from 250,000,000 shares to 350,000,000 shares.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TXMD:US $6.63 USD +0.39

TXMD Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for TXMD.
View Industry Companies
 

Industry Analysis

TXMD

Industry Average

Valuation TXMD Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 63.7x
Price/Book 12.8x
Price/Cash Flow NM Not Meaningful
TEV/Sales 61.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact THERAPEUTICSMD INC, please visit www.therapeuticsmd.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.